Rheumatology is changing. To deliver cutting-edge patient care and lead the field, healthcare professionals need a definitive guide to the clinical discoveries reshaping musculoskeletal and autoimmune medicine.
The latest edition of EMJ Rheumatology is now live, distilling high-impact insights and the biggest advances from EULAR 2026 into a concise, actionable format.
Driving the Future of Rheumatology
We cut through the noise to bring you the evidence-based research shifting clinical practice today:
- Redefining Osteoarthritis: Discover a novel therapy that could completely transform the treatment landscape for osteoarthritis management.
- Addressing Diagnostic Delays: In Sjögren’s disease, why the longest wait is still the journey to an initial diagnosis-and how to bridge the gap.
- From Data to Practice: Practical analysis exploring what it takes to turn EULAR 2026 clinical trial results into improved patient outcomes.
- Timely Clinical Interventions: Highlighting the crucial conversations and knowledge needed to get you-and your patients-to answers sooner.
Expert Analysis, Fully Accessible
Featuring three expert-led features, three exclusive interviews, and extensive clinical coverage, this jam-packed issue is backed by leading voices across the field. We believe the advancements shaping the future of rheumatology should be fully open-access for every practitioner driving the field forward.
Better outcomes start with better knowledge. It’s free, it’s vital, and it’s available now.
